Waklert 150 mg contains armodafinil, a prescription wakefulness-promoting agent used to treat excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder. Armodafinil is also marketed under the brand Nuvigil. In Australia, Waklert 150 mg is sought by individuals requiring improved alertness and sustained cognitive performance under medical supervision.

Armodafinil works by influencing dopamine transporters and other neurotransmitters involved in regulating the sleep–wake cycle. The typical dosage is 150 mg once daily, taken in the morning or before a work shift.

Common side effects may include headache, nausea, insomnia, and anxiety. Waklert should only be used following professional medical evaluation to ensure appropriate dosing, monitor potential side effects, and reduce risks associated with misuse or dependency.